- Home
- XNCR vs BLFS Comparison
XNCR vs BLFS Comparison
Compare XNCR & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | BLFS |
|---|---|---|
| Founded | 1997 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 923.5M |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | XNCR | BLFS |
|---|---|---|
| Price | $11.34 | $23.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $22.33 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 706.8K | 402.8K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.36 | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $125,576,000.00 | $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | $4.80 | $17.82 |
| P/E Ratio | ★ N/A | $1,201.50 |
| Revenue Growth | 13.65 | ★ 16.97 |
| 52 Week Low | $6.92 | $17.86 |
| 52 Week High | $18.69 | $29.57 |
Technical Indicators
Market Signals| Indicator | XNCR | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 65.82 |
| Support Level | $11.02 | $23.74 |
| Resistance Level | $13.28 | $26.30 |
| Average True Range (ATR) | 0.78 | 1.09 |
| MACD | -0.21 | 0.17 |
| Stochastic Oscillator | 28.01 | 89.52 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.